# AI for Cancer Bioinformatics

## Description

Multi-omics integration, tumor subtyping, biomarker discovery, and precision oncology using AI.

## When to use

You are analyzing cancer genomics, transcriptomics, proteomics, pathology images, or clinical data to identify biomarkers or guide oncology decisions.

## Key concepts

- **Multi-omics data integration**: genomics, transcriptomics, epigenomics, proteomics, and metabolomics for a holistic tumor view.
- **Tumor classification and subtyping**: molecular subtypes, histology, and consensus clustering.
- **Somatic mutation and copy-number analysis**: driver mutations, mutational signatures, and tumor heterogeneity.
- **Pathology image and radiomics analysis**: whole-slide imaging and quantitative imaging features.
- **Immunotherapy and targeted-therapy response prediction**: biomarkers such as tumor mutational burden and microsatellite instability.

## Code pattern

```python
import pandas as pd
from sklearn.ensemble import RandomForestClassifier

# Predict molecular subtype from multi-omics features
X = df[['gene_exp_pc1', 'mutational_burden', 'cnv_score', 'tmb']]
y = df['molecular_subtype']
model = RandomForestClassifier(class_weight='balanced', random_state=42).fit(X, y)
```

## Tuning notes

- Account for tumor heterogeneity and microenvironment.
- Use cross-study and external validation; avoid leakage from molecular profiles.
- Handle high dimensionality, batch effects, and missing omics.
- Interpret models for biological plausibility and clinical actionability.

## Verification

1. Integrate two omics layers and cluster tumor samples into subtypes.
2. Predict survival or treatment response and validate on an external cohort.
3. Identify top biomarkers and check consistency with known cancer pathways.

## References

- https://doi.org/10.1016/bs.acr.2024.06.005
- https://bmjoncology.bmj.com/content/3/1/e000134
- https://link.springer.com/article/10.1186/s13073-024-01315-6
- https://www.mdpi.com/2072-6694/16/13/2448
